If you notice any unusual symptoms or if you are concerned about how semaglutide and your IUD might be affecting your body, talk to your doctor right away
Adverse effect management requires awareness of centrally mediated symptoms
This consistency builds confidence in the medications reliability
Clinical trials have shown that semaglutide and liraglutide are generally well tolerated, with gastrointestinal disorders being the most commonly reported AEs, including nausea, diarrhea, vomiting, and constipation, leading to dose reduction or temporary treatment interruption in 12.5% of study participants [40,41,42]
In fact, increased levels of LH and FSH are associated with improved fertility and elevated testosterone levels in male subjects [23, 24]
This multi-receptor approach is designed to produce greater weight reduction than dual or single agonists, as demonstrated in the 2023 phase 2 trial data